Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCTA findings in acute non-arteritic central retinal artery occlusion treated with carbogen inhalation
TCTR20210510007Active, not recruiting
- Sponsor
- N/A
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of carbogen in central retinal artery occlusion (CRAO), sponsored by N/A. Started May 2021; status: active, not recruiting.
02
Drugs
carbogen
03
Conditions
central retinal artery occlusion (CRAO)
Beyond the preview
Go deeper on TCTR20210510007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210510007.